Research progress on m5C methylation and its prospects in tumor immunotherapy / 口腔疾病防治
Journal of Prevention and Treatment for Stomatological Diseases
; (12): 143-148, 2024.
Article
em Zh
| WPRIM
| ID: wpr-1006380
Biblioteca responsável:
WPRO
ABSTRACT
@#Epigenetic modification plays an important role in the biological regulatory process of eukaryotic cells. Tumor immunotherapy is an important means and clinical strategy for the treatment of some cancers. 5-Methylcytosine (m5C) is an important component of the epigenetic regulatory network discovered after m6A and has become a new topic for life science research in recent years. The m5C methylation of RNA can affect the fate of the modified RNA molecules and play an important role in various biological processes, including RNA stability, protein synthesis and transcriptional regulation. Recent studies have shown that m5C writers, erasers and readers are related to a variety of cellular biological processes and systemic diseases, including the occurrence, metastasis and tumor immune microenvironment. m5C methylation can widely affect gene expression and the biological process of tumorigenesis and development at multiple levels, but its specific mechanism and potential interaction with other epigenetic modifications in tumor immunotherapy are still unclear, and its regulatory mechanism, risk assessment and role in targeted therapy for malignant tumors need to be further studied. This article will review the dynamic regulatory network of m5C, the biological role of m5C modification in solid tumors and potential targets in tumor immunotherapy.
Buscar no Google
Base de dados:
WPRIM
Idioma:
Zh
Revista:
Journal of Prevention and Treatment for Stomatological Diseases
Ano de publicação:
2024
Tipo de documento:
Article
País de publicação:
CHINA
/
CN
/
REPUBLIC OF CHINA